90302469 - NEXRETYS

Information

• Trademark
• 90302469

• Source

• Serial Number

  90302469

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  November 06, 2020
  4 years ago

• Transaction Date

  July 25, 2024
  3 months ago

• Status Date

  July 22, 2024
  3 months ago

• Published for Opposition Date

  December 13, 2022
  a year ago

• Location Date

  February 07, 2023
  a year ago

• Status Code

  732

• Current Location

  INTENT TO USE SECTION

  Employee Name

  POWERS, ALEXANDER L

• Attorney Docket Number

  720626006000

  Attorney Name

  Muzamil Huq

  Law Office Assigned Location Code

  L10

• Owners

  • GENERON S.R.L

Case File Statements

• GS0051: Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical diagnostic preparations

Case File Event Statements

• 1/6/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/10/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/30/2021 - 3 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/14/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 4/16/2021 - 3 years ago

  4 - PRIORITY ACTION WRITTEN Type: CPRA

• 4/16/2021 - 3 years ago

  5 - PRIORITY ACTION E-MAILED Type: GPRA

• 4/16/2021 - 3 years ago

  6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 6/16/2021 - 3 years ago

  7 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 9/30/2021 - 3 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/1/2021 - 3 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/20/2022 - 2 years ago

  16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 10/4/2021 - 3 years ago

  11 - SUSPENSION LETTER WRITTEN Type: CNSL

• 10/4/2021 - 3 years ago

  12 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 10/4/2021 - 3 years ago

  13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 4/20/2022 - 2 years ago

  14 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 4/20/2022 - 2 years ago

  15 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 11/8/2022 - 2 years ago

  19 - ASSIGNED TO LIE Type: ALIE

• 5/31/2022 - 2 years ago

  17 - ASSIGNED TO EXAMINER Type: DOCK

• 9/26/2022 - 2 years ago

  18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 11/10/2022 - 2 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/10/2022 - 2 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 11/10/2022 - 2 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/23/2022 - a year ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/13/2022 - a year ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/13/2022 - a year ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/7/2023 - a year ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/7/2023 - a year ago

  29 - SOU EXTENSION 1 GRANTED Type: EX1G

• 8/7/2023 - a year ago

  27 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/7/2023 - a year ago

  28 - SOU EXTENSION 1 FILED Type: EXT1

• 1/22/2024 - 9 months ago

  35 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/5/2024 - 9 months ago

  39 - SOU EXTENSION 2 GRANTED Type: EX2G

• 8/9/2023 - a year ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/3/2024 - 10 months ago

  31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/3/2024 - 10 months ago

  33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/3/2024 - 10 months ago

  32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 1/22/2024 - 9 months ago

  34 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 1/22/2024 - 9 months ago

  36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/5/2024 - 9 months ago

  37 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/5/2024 - 9 months ago

  38 - SOU EXTENSION 2 FILED Type: EXT2

• 2/7/2024 - 9 months ago

  40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/23/2024 - 3 months ago

  42 - SOU EXTENSION 3 FILED Type: EXT3

• 7/23/2024 - 3 months ago

  43 - SOU EXTENSION 3 GRANTED Type: EX3G

• 7/24/2024 - 3 months ago

  44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/22/2024 - 3 months ago

  41 - SOU TEAS EXTENSION RECEIVED Type: EEXT